KCM
AMRX icon

Kendall Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Kendall Capital Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$439K Buy
35,315
+1,050
+3% +$14.1K 0.09% 168
2025
Q4 		$432K Buy
34,265
+8,595
+33% +$98.3K 0.09% 167
2025
Q3 		$257K Buy
25,670
+6,565
+34% +$58.9K 0.06% 210
2025
Q2 		$155K Buy
+19,105
New +$144K 0.04% 217

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kendall Capital Management's AMRX Position: Q1 2026 in Review

Kendall Capital Management increased its Amneal Pharmaceuticals (AMRX) stake by 3.1% in Q1 2026, buying an estimated $14.1K and bringing the position to 35,315 shares worth $439K. The position accounts for 0.09% of the portfolio, ranked #168.

Kendall Capital Management first reported a position in AMRX in Q2 2025 and has held it in 4 quarters since. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Kendall Capital Management held 35,315 shares of Amneal Pharmaceuticals worth $439K as of Q1 2026.
  • Kendall Capital Management bought 1,050 Amneal Pharmaceuticals shares in Q1 2026, an estimated $14.1K.
  • Amneal Pharmaceuticals made up 0.09% of Kendall Capital Management's portfolio in Q1 2026, its #168 holding.
  • Kendall Capital Management first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Kendall Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.